Koshinski Asset Management Inc. Has $1.13 Million Stock Position in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Koshinski Asset Management Inc. grew its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 52.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,589 shares of the pharmacy operator’s stock after buying an additional 9,130 shares during the period. Koshinski Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,127,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Capital Management Corp VA acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $3,473,000. Skylands Capital LLC boosted its stake in Walgreens Boots Alliance by 16.5% in the 2nd quarter. Skylands Capital LLC now owns 149,950 shares of the pharmacy operator’s stock worth $6,356,000 after purchasing an additional 21,200 shares during the period. Pacer Advisors Inc. boosted its stake in Walgreens Boots Alliance by 295.9% in the 2nd quarter. Pacer Advisors Inc. now owns 286,762 shares of the pharmacy operator’s stock worth $12,156,000 after purchasing an additional 214,333 shares during the period. Chicago Capital LLC boosted its stake in Walgreens Boots Alliance by 13.1% in the 2nd quarter. Chicago Capital LLC now owns 16,636 shares of the pharmacy operator’s stock worth $705,000 after purchasing an additional 1,923 shares during the period. Finally, GWM Advisors LLC boosted its stake in Walgreens Boots Alliance by 43.3% in the 2nd quarter. GWM Advisors LLC now owns 19,094 shares of the pharmacy operator’s stock worth $809,000 after purchasing an additional 5,771 shares during the period. 57.12% of the stock is owned by institutional investors.

Shares of NASDAQ:WBA opened at $40.71 on Friday. The company’s 50 day moving average price is $41.39 and its two-hundred day moving average price is $45.26. Walgreens Boots Alliance Inc has a 12-month low of $36.65 and a 12-month high of $64.50. The firm has a market cap of $35.22 billion, a PE ratio of 7.89, a PEG ratio of 1.74 and a beta of 0.55. The company has a quick ratio of 0.33, a current ratio of 0.69 and a debt-to-equity ratio of 0.57.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The business had revenue of $34.63 billion for the quarter, compared to analyst estimates of $34.32 billion. During the same quarter in the previous year, the company earned $1.47 EPS. The business’s revenue for the quarter was up .1% on a year-over-year basis. On average, research analysts expect that Walgreens Boots Alliance Inc will post 4.68 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Wednesday, August 19th will be given a dividend of $0.4675 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date is Tuesday, August 18th. This represents a $1.87 annualized dividend and a dividend yield of 4.59%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 30.55%.

WBA has been the subject of a number of research analyst reports. Morgan Stanley reduced their target price on shares of Walgreens Boots Alliance from $49.00 to $45.00 and set an “equal weight” rating for the company in a research note on Thursday, July 2nd. Bank of America reduced their target price on shares of Walgreens Boots Alliance from $43.00 to $40.00 and set an “underperform” rating for the company in a research note on Friday, July 10th. Citigroup reduced their target price on shares of Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating for the company in a research note on Friday, July 10th. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 target price for the company. in a research note on Friday, July 17th. Finally, Cowen reduced their price objective on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating for the company in a research note on Tuesday, May 19th. Four analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $46.00.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What does earnings per share mean?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.